BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 32711431)

  • 1. Genetic Polymorphism of Epidermal Growth Factor Gene as a Predictor of Hepatocellular Carcinoma in Hepatitis C Cirrhotic Patients.
    Baghdadi I; Abu Ella K; El Shaaraway A; Elshayeb E; El-Rebey HS; El Hoseeny M; Naguib M; Nada A
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2047-2053. PubMed ID: 32711431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients.
    Li Y; Xie Q; Lu F; Zhao J; Mao P; Li Z; Liu S; Zhuang H
    Liver Int; 2010 Jan; 30(1):112-8. PubMed ID: 19840254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.
    Abbas E; Shaker O; Abd El Aziz G; Ramadan H; Esmat G
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):458-63. PubMed ID: 22293333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients.
    Fteah AM; Ahmed AI; Mosaad NA; Hassan MM; Mahmoud SH
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3479-3485. PubMed ID: 31759375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of Toll-like Receptor 3 Gene Polymorphism as a Novel Risk Factor for HCV-related Hepatocellular Carcinoma in Egypt.
    El-Sharawy S; Negm OE; Abd-Elsalam S; El-Sorogy HA; Shehata MAH
    Curr Cancer Drug Targets; 2020; 20(5):382-389. PubMed ID: 32189594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor +61 G/A polymorphism and the risk of hepatocellular carcinoma in a Chinese population.
    Chen K; Wei Y; Yang H; Li B
    Genet Test Mol Biomarkers; 2011 Apr; 15(4):251-5. PubMed ID: 21186997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma.
    Abu Dayyeh BK; Yang M; Fuchs BC; Karl DL; Yamada S; Sninsky JJ; O'Brien TR; Dienstag JL; Tanabe KK; Chung RT;
    Gastroenterology; 2011 Jul; 141(1):141-9. PubMed ID: 21440548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Polymorphism of Epidermal Growth Factor rs4444903 Influences Susceptibility to HCV-Related Liver Cirrhosis and Hepatocellular Carcinoma in a Chinese Han Population.
    Zhang S; Qiao K; Trieu C; Huo Z; Dai Q; Du Y; Lu W; Hou W
    Clin Lab; 2017 Apr; 63(4):845-850. PubMed ID: 28397482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of epidermal growth factor single-nucleotide polymorphism on recurrence of hepatocellular carcinoma after hepatectomy in patients with chronic hepatitis C virus infection.
    Yoshiya S; Fujimoto Y; Bekki Y; Konishi H; Yamashita Y; Ikegami T; Yoshizumi T; Shirabe K; Oda Y; Maehara Y
    Cancer Sci; 2014 Jun; 105(6):646-50. PubMed ID: 24703510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mannose-binding lectin 2 rs11003123 polymorphism is associated with the development of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis in the Chinese population.
    Wang PS; Kuai J; Li H; Wang CG; Shi BJ; Zhong L
    Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):282-8. PubMed ID: 27298104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the Uridine⁻Cytidine Kinase Like-1 Protein and IL28B rs12979860 and rs8099917 SNPs on the Development of Hepatocellular Carcinoma in Cirrhotic Chronic Hepatitis C Patients-A Pilot Study.
    Buivydiene A; Liakina V; Kashuba E; Norkuniene J; Jokubauskiene S; Gineikiene E; Valantinas J
    Medicina (Kaunas); 2018 Sep; 54(5):. PubMed ID: 30344298
    [No Abstract]   [Full Text] [Related]  

  • 13. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
    Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
    Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of PRDM1 gene polymorphism in the progression of hepatocellular carcinoma in Egyptian patients.
    Mohamed AA; Esmail OE; Ibrahim AMA; Makled S; Al-Hussain E; Elsaid A; Alboraie M; El-Awady RR
    J Med Virol; 2023 Jan; 95(1):e28343. PubMed ID: 36424348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of IL-27p28 (rs153109) and TNF-α (rs1800629) Genetic Polymorphisms on the Progression of HCV Infection in Egyptian Patients.
    Tharwat E; Gad GFM; Nazmy MH; Mohamed HI; Hamza N; Wahid A; Ibrahim ARN
    Immunol Invest; 2019 Apr; 48(3):255-267. PubMed ID: 30204505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No association of EGF 5'UTR variant A61G and hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection.
    Qi P; Wang H; Chen YM; Sun XJ; Liu Y; Gao CF
    Pathology; 2009; 41(6):555-60. PubMed ID: 19900104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-Β1 & PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis and HCC in Egyptian Patients with HCV-Related Liver Cirrhosis.
    Nomair AM; Kandil LS; Nomeir HM; Kandil NS
    Asian Pac J Cancer Prev; 2021 Oct; 22(10):3317-3326. PubMed ID: 34711009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of interleukin IL-6 rs-1474347 and IL-10 rs-1800896 genetic polymorphisms on the susceptibility of HCV-infected Egyptian patients to hepatocellular carcinoma.
    Abd El-Baky RM; Hetta HF; Koneru G; Ammar M; Shafik EA; Mohareb DA; Abbas El-Masry M; Ramadan HK; Abu Rahma MZ; Fawzy MA; Fathy M
    Immunol Res; 2020 Jun; 68(3):118-125. PubMed ID: 32504406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms of epidermal growth factor in relation to risk of hepatocellular carcinoma: two case-control studies.
    Yuan JM; Fan Y; Ognjanovic S; Wang R; Van Den Berg D; Govindarajan S; Yu MC
    BMC Gastroenterol; 2013 Feb; 13():32. PubMed ID: 23419149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of genetic polymorphism of BCL-2 (rs2279115) with susceptibility to HCV-related hepatocellular carcinoma.
    Ahmed HS; Wahab EA; Elhady HA; Elgerby MM
    Immunol Res; 2020 Aug; 68(4):189-197. PubMed ID: 32623689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.